Baker McKenzie Advises Biopharma on Sale of Pharmaceutical Business to Stada

Baker McKenzie Advises Biopharma on Sale of Pharmaceutical Business to Stada

Ukraine
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Baker McKenzie has advised the shareholders of Biopharma, a Ukrainian manufacturer of pharmaceuticals and healthcare products, on the carve-out of its non-plasma business and its sale to Stada AG, a global manufacturer of pharmaceuticals and consumer healthcare products. Arzinger reportedly advised Stada on the deal.

Baker McKenzie's team was co-led by Kyiv Partners Viacheslav Yakymchuk and Olha Demianiuk and included Kyiv-based Partner Oksana Simonova, Senior Associate Olha Mikheieva, Associates Andrii Finogin, Olha Sviatenka, and Khrystyna Penyk, as well as London-based Senior Corporate Associate Robert Gray.